Lonza expands in Houston; Dalton grows in Australia and DHL in India;

> Swiss drugmaker Lonza has completed construction of a clean room at its Houston site as it moves further into viral manufacturing. Story

> Fill and finish services helped CMO Dalton Pharma Services score a new Manufacturing Services Agreement with Clarity Pharmaceuticals of Sydney, Australia. Release

> BioCision in July will release new cooling technology to keep samples at a variety of temperatures for hours without ice. Item

> Shipper DHL has opened a 56,000-square-meter warehouse and distribution center in Mumbai, India, aimed at the country's life sciences and healthcare sector, including handling clinical trial services. Item

> Swedish CDMO Recipharm says it has invested €600,000 ($761,442) to expand its injectable drug filling capacity of its facility in Monts, France, capable of filling 7,200 cartridges an hour. Item

> The Federation of East African Pharmaceutical Manufacturers is pushing an initiative to increase production at least 50% in the next several years to make that part of Africa less dependent on drug imports. Story

And Finally... Generic drugmaker Amneal Pharmaceuticals is getting a $3 million boost from New York to help with its $50 million manufacturing project on Long Island where it will expand from 121,000 square feet to 443,000 square feet. Story

Suggested Articles

The FDA has lambasted the Torrent Pharmaceuticals in a warning letter for making OTC meds using water tainted with bacteria.

Eli Lilly is investing $400 million in its Indianapolis site to expand production of insulin and other diabetes meds, and add 100 jobs.

Recipharm has been building its capabilities in sterile injectable and inhalation drugs. Now it is buying a CDMO that manufactures devices for both.